Closed vaccination centers in Rome soon after the Italian government with EU backing stopped a shipment of Astra Zeneca vaccines made in Italy that were being sent to Australia, show the extent of lack of clear direction in the EU on vaccination. Both the European Medicines Agency and the British Health and Medicines Regulatory agency have said that the Astra Zeneca vaccination of people has benefits that far outweighs any reports of risk from rare kind of blood clots. A professor of Imperial College, London, says that "the pause is a disaster for the vaccination uptake in Europe, which was already on slightly unsteady ground in some countries."
Original article 1 minute, gist 1 minute